The Journal of Chemical Research is a peer reviewed, monthly journal, which has a broad international authorship and publishes research papers and reviews in all branches of experimental chemistry.
Established in 1977 as a joint venture by the British, French and German chemical societies it maintains the high standards set by the founding societies. Each paper is independently peer reviewed and only carefully evaluated contributions are accepted.
Recent papers have described new synthetic methods, new heterocyclic compounds, new natural products, and the inorganic chemistry of metal complexes.
The Journal of Chemical Research is a peer reviewed journal that publishes full-length review and research papers in all branches of experimental chemistry. The journal fills a niche by also publishing short papers, a format which favours particular types of work, e.g. the scope of new reagents or methodology, and the elucidation of the structure of novel compounds. Though welcome, short papers should not result in fragmentation of publication, they should describe a completed piece of work. The Journal is not intended as a vehicle for preliminary publications. The work must meet all the normal criteria for acceptance as regards scientific standards.
Papers that contain extensive biological results or material relating to other areas of science may be diverted to more appropriate specialist journals.
Areas of coverage include:
- Organic Chemistry
- Inorganic Chemistry
- Materials Chemistry
- Computational Chemistry
Manuscript Submission Guidelines: Journal of Chemical Research
Please read the guidelines below then visit the Journal’s submission site https://mc.manuscriptcentral.com/chl to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process.
Only manuscripts of sufficient quality that meet the aims and scope of Journal of Chemical Research will be reviewed.
There are no fees payable to submit or publish in this journal.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere. Please see our guidelines on prior publication and note that Journal of Chemical Research does not accept submissions of papers that have been posted on pre-print servers.
- What do we publish?
1.1 Aims & Scope
1.2 Article types
1.3 Writing your paper
1.4 Experimental requirements
1.5 X-Ray crystallographic work
- Editorial policies
2.1 Peer review policy
2.5 Declaration of conflicting interests
2.6 Research ethics and patient consent
2.7 Clinical trials
2.8 Reporting guidelines
2.9 Research Data
- Publishing policies
3.1 Publication ethics
3.2 Contributor's publishing agreement
3.3 Open access and author archiving
- Preparing your manuscript
4.2 Artwork, figures and other graphics
4.3 Supplementary material
4.4 Reference style
4.5 English language editing services
- Submitting your manuscript
5.2 Information required for completing your submission
- On acceptance and publication
6.1 SAGE Production
6.2 Online First publication
6.3 Access to your published article
6.4 Promoting your article
- Further information
7.1 Appealing the publication decision
Before submitting your manuscript to Journal of Chemical Research, please ensure you have read the Aims & Scope.
1.2 Article Types
- Research Papers
There is no limit on the number of references allowed.
The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources. The Journal of Chemical Research also has some specific guidelines, which can be found directly below.
Authors must highlight any possible health and safety problems that could arise from compounds or procedures used in their work. Authors are warned that the use of domestic microwave ovens for chemical purposes can be unreliable and potentially hazardous. Where a domestic oven has been used a note to this effect should beadded to the general experimental section.
In the general experimental methods section, details should be given of any instruments and manufacturers that are used, and also the source of any spectroscopic or analytical services.
Convincing evidence of both purity and identity must be given for all new compounds; this will normally require good elemental analysis which should be quoted to 0.01%, the accuracy should normally be to within ±0.4%. The elemental composition may be defined by a high resolution mass spectrum with an error of not more than 10 ppm, but this must be accompanied by additional evidence of purity. Compounds that have been prepared before should be given the appropriate references. Relevant physical data, such as the melting point, should be quoted for comparison. 1H NMR shifts should be quoted to two decimal places. The multiplicity, relative integrals, and J values should be quoted to one decimal place and assignments given where possible. 13C chemical shifts should be quoted to one decimal place.
Other numerical data should not be quoted to a greater precision than the measurements warrant. Only IR peaks which characterise the functional groups of the compounds should be quoted. For low resolution mass spectra, up to eight major peaks, with the relative intensities, should be given. In general, a detailed discussion of the fragmentation pattern should not be included. Editors or referees may ask to see copies of spectra or of the appropriately authenticated original results of analyses. Authors who are unable to provide these may have their work rejected.
A brief mention of a crystallographic determination may be given in the title. Reference should be made to it in the abstract, without including cell dimensions and other crystal data.
The experimental details of data collection and structure analysis should be concise where routine procedures are used. Brief descriptions of any non-routine procedures should be given. The method used for structure solution and the treatment of H atoms where appropriate should be stated.
A conventional line drawing of the structure should normally be included, except in the simplest cases, and one perspective diagram (or stereo pair) if appropriate. Packing diagrams should not be included unless required to illustrate a specific chemical point. The atom numbering scheme should be shown in one of the diagrams. Each atom of the asymmetric unit should be assigned an Arabic numeral in parentheses following the chemical symbol: C(2), O(12), etc.
The description of the structure may be given in textual or tabular form; the latter is more appropriate if several structure determinations are being reported. Any special details, such as hydrogen bonding, should be mentioned. If significant comment is made on the structures, tables of selected bond parameters with estimated standard deviations can be included. Such a table should be restricted to significant dimensions only (e.g. it is rarely necessary to include data for phenyl rings). Differences from expected norms should be noted. The experimental section of the paper should include the following:
- The crystal data, including the forumla, Mr.
- The space group, cell dimensions and volume.
- The number of formula units in the unit cell (Z).
- The wavelength of the radiation and the linear absorption coefficient (u).
- The diffractometer that was used and the range for collection data (a, h, k, l).
- The total number of reflections that were collected, the number of independent reflections and the number that were used in the structure determination.
- The programmes that were used, including appropriate citations.
- The R factors and residual electron density, peak and hole.
- Details of where the data have been deposited and the accesion number.
Journal of Chemical Research expects that the data will have been submitted to the CCDC or equivalent centre. A check list of items for deposition is available from the CCDC either by E-mail to email@example.com with the one-line message sendme depform or through http://www.ccdc.cam.ac.uk/; the form can be saved as a simple text file. CCDC information should be listed in the ESI. The data that are deposited must include:
(1) A table of final fractional atomic coordinates.
(2) Any calculated coordinates (e.g. of hydrogen).
(3) A full list of bond lengths and angles with estimated standard deviations.
(4) A full list of displacement parameters in the form Bij or Uij (in Å2or pm²).
Tables of structure factors (F0, Fc) should not be sent, but retained by the authors so that they can be made available to the referees if requested. The CIF and a CheckCIF report must be submitted with the paper. Referees will require that a satisfactory response is given to any significant alerts that the report has raised.
The experimental details of the data collection and structure analysis for an X-ray structure should be tabulated and the CCDC number should be listed in the text as Electronic Supplementary Information (ESI) and not as a note in the references. A planar structure should also be given as well as the ORTEP structure.
Authors should present large table of data including crystallographic data, extensive theoretical calculations and biological results together with copies of spectra and electron microscopy pictures in the ESI. Editors may require the transfer of information from the text to the ESI. The content of the ESI should be briefly listed at the end of the experimental section.
Journal of Chemical Research will consider articles that contain computational results which support the experimental work described in the paper. The journal is not a vehicle for the publication of purely theoretical papers. In the results and discussion section of the text, the authors should give the name of the software that they have chosen to use. They should explain why its use was appropriate and any deviations that they have made from the default settings together with any specific constraints that they have applied to the particular calculations to achieve their objectives. The software used should be correctly referenced. Authors should show how the results of their calculations relate to the main experimental objectives of the paper.
In the experiemental section of the paper, the authors should provide the following details, which should be appropriately referenced. (a) the origin of the input file or visualisation tool; if the calculations from one piece of software have been used as the input for another, authors should show how this has been done; (b) the name and version of the software, level of theory and basis set used; (c) the nature and objectives of the calculations; (d) any deviations from the default settings of the software; (e) any specific constraints which have been applied to the particular calculations; and (f) the processes that were used to handle and present the results.
In addition, authors must retain the actual input and output files so that they can be made available to referees if requested. When the details of the calculations are given as Electronic Supplementary Information, the details of the methodology should be expanded.
Journal of Chemical Research operates a conventional single-blind reviewing policy in which the reviewer’s name is always concealed from the submitting author.
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
(i) Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
(ii) Drafted the article or revised it critically for important intellectual content,
(iii) Approved the version to be published,
(iv) Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
2.3.1 Writing assistance
Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.
Journal of Chemical Research requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
It is the policy of Journal of Chemical Research to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’. For guidance on conflict of interest statements, please see the ICMJE recommendations here.
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please do not submit the patient’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants.
Journal of Chemical Research conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.
At SAGE we are committed to facilitating openness, transparency and reproducibility of research. Where relevant, Journal of Chemical Research encourages authors to share their research data in a suitable public repository subject to ethical considerations and where data is included, to add a data accessibility statement in their manuscript file. Authors should also follow data citation principles. For more information please visit the Research Data Sharing Policies, which includes information about SAGE’s partnership with the data repository Figshare.
SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway.
Journal of Chemical Research and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.
3.1.2 Prior publication
If material has been previously published it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit the SAGE Author Gateway.
Journal of Chemical Research offers optional open access publishing via the SAGE Choice programme. For more information please visit the SAGE Choice website. For information on funding body compliance, and depositing your article in repositories, please visit SAGE Publishing Policies on our Journal Author Gateway.
The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines.
Figures supplied in colour will appear in colour online and in the print issue. There is no charge for reproducing figures in colour in the printed version.
This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplemental files.
Journal of Chemical Research adheres to the SAGE Vancouver reference style. View the SAGE Vancouver guidelines to ensure your manuscript conforms to this reference style.
Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.
Journal of Chemical Research is hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit https://mc.manuscriptcentral.com/chl to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.
As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.
The collection of ORCID IDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID ID you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID ID will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID ID is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.
You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. The affiliation listed in the manuscript should be the institution where the research was conducted. If an author has moved to a new institution since completing the research, the new affiliation can be included in a manuscript note at the end of the paper. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).
Please also ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the SAGE Author Gateway.
Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be made available to the corresponding author via our editing portal SAGE Edit or by email, and corrections should be made directly or notified to us promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorising the change.
6.2 Online First publication
Online First allows final articles (completed and approved articles awaiting assignment to a future issue) to be published online prior to their inclusion in a journal issue, which significantly reduces the lead time between submission and publication. Visit the SAGE Journals help page for more details, including how to cite Online First articles.
SAGE provides authors with online access to their final article.
Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice. In addition, SAGE is partnered with Kudos, a free service that allows authors to explain, enrich, share, and measure the impact of their article. Find out how to maximise your article’s impact with Kudos.
6.4.1 Make your article discoverable
For information and guidance on how to make your article more discoverable, visit our Gateway page on How to Help Readers Find Your Article Online.
Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Journal of Chemical Research editorial office as follows:
Editors have very broad discretion in determining whether an article is an appropriate fit for their journal. Many manuscripts are declined with a very general statement of the rejection decision. These decisions are not eligible for formal appeal unless the author believes the decision to reject the manuscript was based on an error in the review of the article, in which case the author may appeal the decision by providing the Editor with a detailed written description of the error they believe occurred.
If an author believes the decision regarding their manuscript was affected by a publication ethics breach, the author may contact the publisher with a detailed written description of their concern, and information supporting the concern, at firstname.lastname@example.org.